Our blog

Positive result from the Pivotal trial with levodopa administered by continuous subcutaneous infusion

8 de May de 2023

Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with…

Compartir:
Posted in: Parkinson

New inhaled levodopa INBRIJA authorised in Spain

8 de May de 2023

The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured…

Compartir:
Posted in: Parkinson

new drug for early-stage Alzheimer’s disease

16 de January de 2023

On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer’s…

Compartir:

We tested a drug to treat agitation in Alzheimer’s patients

3 de June de 2021

The General University Hospital of Catalonia is the first recognized center in Europe to evaluate…

Compartir:
Posted in: Alzeimer, Uncategorised

The General University Hospital of Catalonia (HUGC), through the Clinical Research Unit (UDIC), has included the world’s first patient in a phase I clinical trial on Alzheimer’s.

3 de June de 2021

This study could improve the efficacy and safety of the products being evaluated to try…

Compartir:
Posted in: Alzeimer, Uncategorised

FDA approves sublingual apomorphine in off periods

22 de July de 2020

The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson’s…

Compartir:
Posted in: Parkinson, Uncategorised

US authorizes an intranasal levodopa.

8 de April de 2020

An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija….

Compartir:
Posted in: Parkinson

Levodopa infusion pump

2 de April de 2020

Levodopa infusion pump We evaluate an ultraconcentrated levodopa administered subcutaneously in patients with motor fluctuations….

Compartir:
Posted in: Parkinson

Activation of phase I trial in Progressive Supranuclear Palsy

11 de March de 2020

Our Unit has achieved to be activated in this outstanding project and so serious pathology….

Compartir:
Posted in: Parkinson

We continue a phase I clinical trial in Parkinson

5 de March de 2020

We appreciate the great effort made by our patients to contribute to the development of…

Compartir:
Posted in: Parkinson

An amazing Phase I trial in Parkinson

9 de January de 2020

We have been activated in this trial that evaluates the safety of an innovative compound…

Compartir:
Posted in: Parkinson

Our clinical trials unit remains in prominent position

9 de January de 2020

We have reached the first position, in December 2019, in the international inclusion of patients…

Compartir:
Posted in: Alzeimer, News, Parkinson
Page 1 of 31 2 3

Compartir: